Skip to content

Perrigo Company PRGO Common stock, shares authorized (in shares)

Common stock, shares authorized (in shares) at other companies

Abbott logo
AbbottABT
PBH
Prestige Consumer HealthcarePBH
Kenvue logo
KenvueKVUE
Ollie's Bargain Outlet Holdings, Inc. logo
Ollie's Bargain Outlet Holdings, Inc.OLLI
Coty logo
CotyCOTY
CVS Health logo
CVS HealthCVS

Other financials

Income statement

See full
Revenue$969.2M-7.2%
Gross profit$325.5M-17.0%
Operating income-$372.3M-894%
Net income-$398.6M-6,128%
EPS (diluted)-$2.87-5,640%

Balance sheet

See full
Cash & equivalents$357.2M-12.9%
Total debt$3.8B-0.6%
Total equity$2.5B-42.7%
Total assets$8.0B-18.2%

Cash flow

See full
Operating cash flow-$113.6M-76.1%
CapEx$13.8M-45.9%
Free cash flow-$127.4M-41.6%

Valuation

See full
Market cap$1.35B-62.9%
Enterprise value$4.82B-32.0%
P/S0.3×-0.5×

Profitability

See full
Gross margin34.2%-2.2pp
Operating margin-36.9%-41.8pp
Net margin-43.5%-48.6pp
FCF margin4.2%-2.0pp

Returns & leverage

See full
Return on equity-53%-57.7pp
Debt / equity1.5×+0.6×
Current ratio2.7×+0.4×

Where this comes from

Reported directly by Perrigo Company in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.

The official record: Perrigo Company’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Perrigo Company's common stock, shares authorized (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Perrigo Company's common stock, shares authorized (in shares)?
Perrigo Company (PRGO) reported common stock, shares authorized (in shares) of $10B in Q1 2026.
How has Perrigo Company's common stock, shares authorized (in shares) changed year-over-year?
Perrigo Company's common stock, shares authorized (in shares) decreased by 0.0% year-over-year, from $10B to $10B.
What is the long-term trend for Perrigo Company's common stock, shares authorized (in shares)?
Over 5 years (2020 to 2025), Perrigo Company's common stock, shares authorized (in shares) has grown at a 0.0% compound annual growth rate (CAGR), from $10B to $10B.